TY  - JOUR
A1  - Brünnert, Daniela
A1  - Seupel, Raina
A1  - Goyal, Pankaj
A1  - Bach, Matthias
A1  - Schraud, Heike
A1  - Kirner, Stefanie
A1  - Köster, Eva
A1  - Feineis, Doris
A1  - Bargou, Ralf C.
A1  - Schlosser, Andreas
A1  - Bringmann, Gerhard
A1  - Chatterjee, Manik
T1  - Ancistrocladinium A induces apoptosis in proteasome inhibitor-resistant multiple myeloma cells: a promising therapeutic agent candidate
T2  - Pharmaceuticals
N2  - The N,C-coupled naphthylisoquinoline alkaloid ancistrocladinium A belongs to a novel class of natural products with potent antiprotozoal activity. Its effects on tumor cells, however, have not yet been explored. We demonstrate the antitumor activity of ancistrocladinium A in multiple myeloma (MM), a yet incurable blood cancer that represents a model disease for adaptation to proteotoxic stress. Viability assays showed a potent apoptosis-inducing effect of ancistrocladinium A in MM cell lines, including those with proteasome inhibitor (PI) resistance, and in primary MM cells, but not in non-malignant blood cells. Concomitant treatment with the PI carfilzomib or the histone deacetylase inhibitor panobinostat strongly enhanced the ancistrocladinium A-induced apoptosis. Mass spectrometry with biotinylated ancistrocladinium A revealed significant enrichment of RNA-splicing-associated proteins. Affected RNA-splicing-associated pathways included genes involved in proteotoxic stress response, such as PSMB5-associated genes and the heat shock proteins HSP90 and HSP70. Furthermore, we found strong induction of ATF4 and the ATM/H2AX pathway, both of which are critically involved in the integrated cellular response following proteotoxic and oxidative stress. Taken together, our data indicate that ancistrocladinium A targets cellular stress regulation in MM and improves the therapeutic response to PIs or overcomes PI resistance, and thus may represent a promising potential therapeutic agent.
KW  - multiple myeloma
KW  - ancistrocladinium A
KW  - naphthylisoquinoline alkaloids
KW  - proteasome inhibitor resistance
KW  - RNA splicing
KW  - cellular stress response
KW  - proteasome subunit beta type-5 (PSMB5)
KW  - activating transcription factor 4 (ATF4)
KW  - ataxia teleagiectasia mutated (ATM)
KW  - H2A histone family member X (H2AX)
Y1  - 2023
UR  - https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/36288
UR  - https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-362887
SN  - 1424-8247
VL  - 16
IS  - 8
ER  -